Health Products (Therapeutic Products) (Amendment) Regulations 2018

No. S 119

Health Products Act

(CHAPTER 122D)

Health Products (Therapeutic Products)
(Amendment) Regulations 2018

In exercise of the powers conferred by section 72 of the Health Products Act, the Health Sciences Authority, with the approval of the Minister for Health, makes the following Regulations:

Citation and commencement

1. These Regulations are the Health Products (Therapeutic Products) (Amendment) Regulations 2018 and come into operation on 1 March 2018.

Amendment of regulation 2

2. Regulation 2 of the Health Products (Therapeutic Products) Regulations 2016 (G.N. No. S 329/2016) (called in these Regulations the principal Regulations) is amended —

(a)

by inserting, immediately after the definition of “Authority’s website” in paragraph (1), the following definition:

“ “collaborative prescribing practitioner” has the same meaning as in regulation 56C(6) of the Private Hospitals and Medical Clinics Regulations (Cap. 248, Rg 1);”;

(b)

by deleting paragraph (a) of the definition of “dispense” in paragraph (1) and substituting the following paragraph:

“(a)	a qualified practitioner or collaborative prescribing practitioner, or a person acting under the supervision of a qualified practitioner or collaborative prescribing practitioner; or”; and

(c)

by deleting the words “qualified practitioner” in paragraph (2)(a) and (b)(ii) and (v) and substituting in each case the words “qualified practitioner or collaborative prescribing practitioner”.

Amendment of regulation 11

3. Regulation 11 of the principal Regulations is amended —

(a)

by deleting the words “qualified practitioner” in paragraph (b) and substituting the words “qualified practitioner or collaborative prescribing practitioner”; and

(b)

by deleting paragraph (c) and substituting the following paragraph:

“(c)

the following requirements are satisfied:

(i)	the person is a qualified practitioner or collaborative prescribing practitioner, or a person acting in accordance with the oral or written instructions of a qualified practitioner or collaborative prescribing practitioner;
(ii)	the supply is made to a patient under the care of the qualified practitioner or collaborative prescribing practitioner; or”.

Amendment of regulation 12

4. Regulation 12 of the principal Regulations is amended by deleting paragraph (a) and substituting the following paragraph:

“(a)	the person is a qualified practitioner or collaborative prescribing practitioner, or a person acting in accordance with the oral or written instructions of a qualified practitioner or collaborative prescribing practitioner; or”.

Amendment of regulation 13

5. Regulation 13(1) of the principal Regulations is amended —

(a)

by deleting the words “qualified practitioner” in sub‑paragraph (b) and substituting the words “qualified practitioner or collaborative prescribing practitioner”; and

(b)

by deleting sub-paragraph (c) and substituting the following sub‑paragraph:

“(c)

the following requirements are satisfied:

(i)	the person is a qualified practitioner or collaborative prescribing practitioner, or a person acting in accordance with the oral or written instructions of a qualified practitioner or collaborative prescribing practitioner;
(ii)	the supply is made to a patient under the care of the qualified practitioner or collaborative prescribing practitioner.”.

Amendment of regulation 16

6. Regulation 16 of the principal Regulations is amended by deleting the words “qualified practitioner” in paragraphs (1) and (2)(d) and substituting in each case the words “qualified practitioner or collaborative prescribing practitioner”.

Amendment of regulation 17

7. Regulation 17 of the principal Regulations is amended —

(a)

by deleting the words “qualified practitioner” in paragraph (2)(a) and (b) and substituting in each case the words “qualified practitioner or collaborative prescribing practitioner”; and

(b)

by deleting sub-paragraph (a) of paragraph (3) and substituting the following sub-paragraph:

“(a)	a qualified practitioner or collaborative prescribing practitioner, or a person acting under the supervision of a qualified practitioner or collaborative prescribing practitioner; or”.

[G.N. No. S 219/2017]

Made on 1 February 2018.

KANDIAH SATKUNANANTHAM

Chairman,
Health Sciences Authority,
Singapore.

[HSA/Legal/2018:02; AG/LEGIS/SL/122D/2015/12 Vol. 1]

(To be presented to Parliament under section 72(5) of the Health Products Act).

Search within Legislation